Biologic Rationale, Development History, and Practical Dosing and Administration

In this presentation from the "CDK 4/6 Inhibitor Therapy for ER+ Metastatic Breast Cancer - Advancing Nursing Care to Improve Patient Outcomes" symposium held during the 2016 Annual Meeting ... Author: imedex Added: 05/31/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts